Perspectives in Urology Point Counterpoint 2018

Genetic Testing and Next Generation DNA Sequencing

Alan H. Bryce, MD, explains the concept of synthetic lethality in the context of BRCA-deficient tumors, as well as resistance to poly (ADP-ribose) polymerase (PARP) inhibition. He also discusses the under-utilization of inherited cancer risk syndromes in prostate cancer practice, research, and guidelines, as well as new pathways for therapeutic targeting

Read More

Join the GRU Community

- Why Join? -